ARCHIVES

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

This article is from The Cancer Letter archive.

Vol. 23 No. 06 | February 14, 1997

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

NCI Offers Model Informed Consent Documents

November 6, 1998

In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day

October 23, 1992

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994